Results 111 to 120 of about 14,357 (275)

Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives

Romanian Journal of Internal Medicine
Factor XI is a zymogen with an important role in the coagulation cascade. It is activated by FXII, thrombin and or it can be autoactivated. It has a prothrombotic effect after being activated by thrombin, but also through its antifibrinolytic action ...
Vlădăreanu Ana-Maria, Roşca Adrian
doaj   +1 more source

Tranexamic Acid Treatment of Life-Threatening Hematuria in Polycystic Kidney Disease

International Journal of Nephrology, 2011
A 41-year-old woman with autosomal dominant polycystic kidney disease had chronic kidney disease class IV. She presented 10 days postpartum with a 4-day history of severe hematuria, left flank pain, and anemia, hemoglobin 62 g/L. CT scan showed massively
Turki AlAmeel, Michael West
doaj   +1 more source

Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery [PDF]

, 2010
Ehrenfried Schindler, Joachim Photiadis, Nicodème Sinzobahamvya, Albert Döres, Boulos Asfour, Victor Hraska   +5 more
openalex   +1 more source

Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage

Brain and Spine, 2022
M. Germans, W. Dronkers, M. Baharoglu, R. Post, D. Verbaan, G. Rinkel, Y. Roos   +6 more
doaj   +1 more source

Antimicrobial, antifibrinolytic, enzyme inhibitory and wound healing properties of zinc borate

, 2023
Rukiye Boran, Tuba Baygar, Nurdan Saraç, Semih Ayrıkçil, Derviş Yılmaz, Aysel Uğur   +5 more
openalex   +1 more source

Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage [PDF]

, 2017
Background Fibrinolysis contributes to coagulopathy after major trauma and surgery. We hypothesized that progressive haemodilution is responsible, at least in part, for increased fibrinolytic tendency of blood clot. Methods The study was performed in two
Bolliger, D., Levy, J. H., Molinaro, R. J., Szlam, F., Tanaka, K. A.   +4 more
core  

Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation

Frontiers in Pharmacology
BackgroundAtrial fibrillation (AF) is a cardiac arrhythmia characterized by disorganized atrial electrical activity, resulting in ineffective mechanical contraction and a heightened propensity for intra-atrial thrombus formation.
Helton Jose Reis, Luana Bernardes Xavier Costa, Gabriela Lopes Martins, Rita Carolina Figueiredo Duarte, Luma Clara Martins Costa, Estêvão Lanna Figueiredo, Francisco Rezende Silveira, Nathália Greco Coelho, Maria das Graças Carvalho, Luciene Bruno Vieira, Edna Afonso Reis, Karina Braga Gomes, Cláudia Natália Ferreira, Cláudia Natália Ferreira   +13 more
doaj   +1 more source

Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions [PDF]

, 2015
Karin PM van Galen, Eveline T Engelen, Evelien P. Mauser‐Bunschoten, Robert JJ van Es, Roger E. G. Schutgens   +4 more
openalex   +1 more source

Haematological and infectious complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease [PDF]

, 2017
A complication is an event or occurrence that is associated with a disease or a healthcare intervention, is a departure from the desired course of events, and may cause, or be associated with, suboptimal outcome.
Bronicki, Ronald, Checchia, Paul A., Dodge-Khatami, Ali, Karamlou, Tara, Maruszewski, Bohdan, Ohye, Richard G.   +5 more
core  

Antifibrinolytics in subarachnoid haemorrhage

International Journal of Clinical Practice, 1985
S A, Tsementzis, E R, Hitchcock
openaire   +2 more sources